Checkmate Pharmaceuticals
Checkmate Pharmaceuticals is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Checkmate Pharmaceuticals Information
Checkmate Pharmaceuticals was acquired by
Regeneron.
The acquisition happend on 2022-04-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 245 Main Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Financial Info
Stage:
series c
Raised Last:
$85M
Raised Total:$170M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Checkmate Pharmaceuticals is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Contact Phone:
+16176823625
Contact Email:
Checkmate Pharmaceuticals went public on 8/6/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/6/2020
IPO Valuation:
$322M
Ticker Symbol:
CMPI
IPO Price:
$15/share
Amount Raised:
$75M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
